This is a StreetInsider.com Premium Only Page

Biogen (BIIB) – Major News

Apr 24, 2024 06:46 AM Biogen (BIIB) Tops Q1 EPS by 24c; reaffirms guidance

Feb 13, 2024 07:00 AM Biogen (BIIB) Misses Q4 EPS by 23c, Offers Guidance

Nov 8, 2023 07:04 AM Biogen (BIIB) Tops Q3 EPS by 37c; cuts EPS forecast

Jul 28, 2023 06:49 AM Biogen (BIIB) in talks to acquire Reata Pharma (RETA) - Bloomberg

Jul 25, 2023 07:02 AM Biogen (BIIB) Tops Q2 EPS by 24c, Offers Guidance

Apr 25, 2023 07:04 AM Biogen (BIIB) Tops Q1 EPS by 12c, Offers Guidance

Feb 15, 2023 07:02 AM Biogen (BIIB) Tops Q4 EPS by 57c, Offers Guidance

Oct 25, 2022 07:06 AM Biogen (BIIB) Tops Q3 EPS by 63c, Raises Guidance

Sep 28, 2022 07:00 AM Eisai, Biogen (BIIB) Announce Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint for Reduction of Early Alzheimer's Disease

Jul 20, 2022 07:02 AM Biogen (BIIB) Tops Q2 EPS by $1.12; Raises Outlook

May 3, 2022 07:03 AM Biogen (BIIB) Misses Q1 EPS by 76c, Announces CEO Transition

Feb 3, 2022 07:11 AM Biogen (BIIB) Misses Q4 EPS by 1c, ADUHELM Sales Just $1 Million ; Lowers FY Guidance

Dec 29, 2021 11:59 PM Samsung BioLogics Said Biogen (BIIB) Buyout Rumor 'Untrue'

Oct 20, 2021 07:05 AM Biogen (BIIB) Tops Q3 EPS by 66c, Updates FY Guidance

Jul 22, 2021 07:03 AM Biogen (BIIB) Tops Q2 EPS by $1.13, Offers FY Guidance

Jun 7, 2021 11:03 AM FDA Announces Approve of Biogen's (BIIB) Treatment for Alzheimer's Disease

Apr 22, 2021 07:02 AM Biogen (BIIB) Tops Q1 EPS by 30c, Updates Guidance

Feb 3, 2021 07:09 AM Biogen (BIIB) Misses Q4 EPS by 29c, Guides FY Below Consensus

Nov 9, 2020 06:41 AM Biogen (BIIB) Confirms Negative FDA Advisory Committee Votes on Aducanumab in Alzheimer's Disease

Oct 21, 2020 07:06 AM Biogen (BIIB) Tops Q3 EPS by 71c, Updates Guidance, Approves $5 Billion Buyback

Jul 22, 2020 06:52 AM Biogen (BIIB) Tops Q2 EPS by $2.22, Guidance Beats

Jul 22, 2020 06:32 AM Biogen (BIIB) CFO Jeffrey Capello Steps Down, Michael McDonnell Named to Position

Apr 22, 2020 07:04 AM Biogen (BIIB) Tops Q1 EPS by $1.40

Jan 30, 2020 06:53 AM Biogen (BIIB) Tops Q4 EPS by 34c, Offers FY20 Guidance

Oct 22, 2019 06:53 AM Biogen (BIIB) Tops Q3 EPS by 90c

Oct 22, 2019 06:33 AM Biogen (BIIB) Says it Plans Regulatory Filing for Aducanumab in Alzheimer's Disease After Consulting with FDA

Jul 23, 2019 06:34 AM Biogen (BIIB) Tops Q2 EPS by $1.62, Raises FY Guidance

Apr 24, 2019 06:31 AM Biogen (BIIB) Tops Q1 EPS by 14c

Mar 4, 2019 05:53 AM Biogen (BIIB) to Acquire Nightstar Therapeutics (NITE) for $25.50/Sh in Deal Valued at Approx. $800M

Jan 29, 2019 06:33 AM Biogen (BIIB) Tops Q4 EPS by 25c, Offers Guidance

Oct 23, 2018 06:32 AM Biogen (BIIB) Tops Q3 EPS by 62c

Jul 24, 2018 06:39 AM Biogen (BIIB) Tops Q2 EPS by 56c, FY Guidance Tops Consensus

Apr 24, 2018 07:00 AM Biogen (BIIB) Tops Q1 EPS by 13c, Miss on Revenues

Jan 25, 2018 06:33 AM Biogen (BIIB) Misses Q4 EPS by 19c, Revenue Beats; Offers Outlook

Oct 24, 2017 07:00 AM Biogen (BIIB) Tops Q3 EPS by 61c

Jul 25, 2017 06:31 AM Biogen (BIIB) Tops Q2 EPS by 59c, Sales Beat; Raises Outlook

Apr 25, 2017 07:00 AM Biogen (BIIB) Tops Q1 EPS by 20c

Jan 26, 2017 06:32 AM Biogen (BIIB) Tops Q4 EPS by 8c; FY17 Rev Guidance Falls Below the Street

Jan 17, 2017 07:31 AM Biogen (BIIB), Forward Pharma (FWP) Enter Settlement and License Agreement; Biogen to Pay $1.25B, Royalties

Dec 27, 2016 05:45 AM Biogen (BIIB) Receives FDA Approval for SPINRAZA to Treat SMA (IONS)

Dec 20, 2016 04:02 PM Biogen (BIIB) Approves Separation of Bioverativ (BIVV); Declares Special Dividend

Dec 19, 2016 04:20 PM Biogen (BIIB) Names Michel Vounatsos CEO

Oct 26, 2016 07:00 AM Biogen (BIIB) Tops Q3 EPS by 22c

Aug 2, 2016 02:49 PM Biogen (BIIB) Draws Takeover Interest from Allergan (AGN), Merck (MRK) - DJ

Aug 2, 2016 02:46 PM Biogen (BIIB) Shares Active on M&A Chatter

Jul 21, 2016 07:02 AM Biogen (BIIB) Tops Q2 EPS by 53c; CEO Scangos to Step Down

May 3, 2016 07:31 AM Biogen (BIIB) Plans to Spinoff Hemophilia Business into Independent, Publicly-Traded Company

Apr 21, 2016 07:16 AM Biogen (BIIB) Tops Q1 EPS by 33c

Jan 27, 2016 07:16 AM Biogen (BIIB) Tops Q4 EPS by 42c; Guides In-Line

Oct 21, 2015 07:32 AM Biogen's (BIIB) Phase 3 ASCEND Trial Missed Primary, Secondary Endpoints